A prospective observational study of prevalence and outcomes of patients with Gold Standard Framework criteria in a tertiary regional Australian Hospital.


Journal

BMJ supportive & palliative care
ISSN: 2045-4368
Titre abrégé: BMJ Support Palliat Care
Pays: England
ID NLM: 101565123

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 08 02 2015
revised: 07 07 2015
accepted: 06 09 2015
pubmed: 24 9 2015
medline: 4 6 2019
entrez: 23 9 2015
Statut: ppublish

Résumé

Report the use of an objective tool, UK Gold Standards Framework (GSF) criteria, to describe the prevalence, recognition and outcomes of patients with palliative care needs in an Australian acute health setting. The rationale for this is to enable hospital doctors to identify patients who should have a patient-centred discussion about goals of care in hospital. Prospective, observational, cohort study. Adult in-patients during two separate 24 h periods. Prevalence of in-patients with GSF criteria, documentation of treatment limitations, hospital and 1 year survival, admission and discharge destination and multivariate regression analysis of factors associated with the presence of hospital treatment limitations and 1 year survival. Of 626 in-patients reviewed, 171 (27.3%) had at least one GSF criterion, with documentation of a treatment limitation discussion in 60 (30.5%) of those patients who had GSF criteria. Hospital mortality was 9.9%, 1 year mortality 50.3% and 3-year mortality 70.2% in patients with GSF criteria. One-year mortality was highest in patients with GSF cancer (73%), renal failure (67%) and heart failure (60%) criteria. Multivariate analysis revealed age, hospital length of stay and presence of the GSF chronic obstructive pulmonary disease criteria were independently associated with the likelihood of an in-hospital treatment limitation. Non-survivors at 3 years were more likely to have a GSF cancer (25% vs 6%, p=0.004), neurological (10% vs 3%, p=0.04), or frailty (45% vs 3%, p=0.04) criteria. After multivariate logistic regression GSF cancer criteria, renal failure criteria and the presence of two or more GSF clinical criteria were independently associated with increased risk of death at 3 years. Patients returning home to live reduced from 69% (preadmission) to 27% after discharge. The use of an objective clinical tool identifies a high prevalence of patients with palliative care needs in the acute tertiary Australian hospital setting, with a high 1 year mortality and poor return to independence in this population. The low rate of documentation of discussions about treatment limitations in this population suggests palliative care needs are not recognised and discussed in the majority of patients. 11/121.

Identifiants

pubmed: 26391750
pii: bmjspcare-2015-000864
doi: 10.1136/bmjspcare-2015-000864
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-99

Informations de copyright

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Auteurs

Sharyn Milnes (S)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.
Department of Medicine, Deakin University School of Medicine, Barwon Health, Geelong, Victoria, Australia.

Neil R Orford (NR)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.
Department of Medicine, Deakin University School of Medicine, Barwon Health, Geelong, Victoria, Australia.
Department of Epidemiology and Preventive Medicine (DEPM), Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.

Laura Berkeley (L)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.

Nigel Lambert (N)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.
Southern GP Training (SGPT), Drysdale Clinic, Geelong, Victoria, Australia.

Nicholas Simpson (N)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.

Tania Elderkin (T)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.

Charlie Corke (C)

Intensive Care Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia.
Department of Medicine, Deakin University School of Medicine, Barwon Health, Geelong, Victoria, Australia.

Michael Bailey (M)

Department of Epidemiology and Preventive Medicine (DEPM), Australian and New Zealand Intensive Care Research Centre (ANZIC-RC), Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH